Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES INC.

BRIGHT MINDS BIOSCIENCES clinical programs — 1063 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

1,063 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,063 programs

Clinical programs

Page 15 of 23

  1. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    MDMA ('Ecstasy')

    phase 1 small molecule completed

    1 trial

  2. MDMA

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolism

    phase 1 small molecule completed

    1 trial

  3. Marijuana

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  4. Marijuana via vape device

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 small molecule active

    1 trial

  5. Marinol 10Mg Capsule TMS Sham

    BRIGHT MINDS BIOSCIENCES INC.

    Neurosciences

    phase 1 small molecule completed

    1 trial

  6. Medium THC

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Impairment

    phase 1 small molecule completed

    1 trial

  7. Memantine

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

  8. Meningococcal ACYW135 Polysaccharide Conjugate Vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Meningitis, Meningococcal

    phase 1 mab active

    1 trial

  9. Mepolizumab

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Subjects

    phase 1 mab completed

    1 trial

  10. Methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate-Related Disorders

    phase 1 small molecule completed

    1 trial

  11. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Use Disorder

    phase 1 small molecule completed

    1 trial

  12. Methamphetamine

    BRIGHT MINDS BIOSCIENCES INC.

    Stimulant Use

    phase 1 small molecule completed

    1 trial

  13. Methamphetamine (Desoxyn®)

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Abuse

    phase 1 small molecule completed

    1 trial

  14. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 small molecule active

    1 trial

  15. Methylphenidate

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorder

    phase 1 small molecule completed

    1 trial

  16. Metronidazole gel 1

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule completed

    1 trial

  17. Mindful Awareness in Body-oriented Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use Disorder

    phase 1 other completed

    1 trial

  18. Mindfulness Training for Smokers

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 other completed

    1 trial

  19. Mindfulness-Oriented Recovery Enhancement

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    phase 1 other completed

    1 trial

  20. Minnelide™Capsules

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  21. Modafinil and Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  22. Mometasone furoate drug formulation (MFF) 1

    BRIGHT MINDS BIOSCIENCES INC.

    Hypersensitivity

    phase 1 small molecule completed

    1 trial

  23. Morphine Sulfate

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  24. Motivational Interviewing

    BRIGHT MINDS BIOSCIENCES INC.

    Schizophrenia

    phase 1 other completed

    1 trial

  25. Motivational Network Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Use

    phase 1 other completed

    1 trial

  26. Multi-media WINGS

    BRIGHT MINDS BIOSCIENCES INC.

    Intimate Partner Violence

    phase 1 other completed

    1 trial

  27. Mycophenolate Mofetil

    BRIGHT MINDS BIOSCIENCES INC.

    Hematopoietic Stem Cell Transplantation

    phase 1 small molecule active

    1 trial

  28. N-acetyl cysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 1 small molecule completed

    1 trial

  29. ND-003 40mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  30. NDX-1017

    BRIGHT MINDS BIOSCIENCES INC.

    Alzheimer Disease

    phase 1 small molecule completed

    1 trial

  31. NP-G2-044

    BRIGHT MINDS BIOSCIENCES INC.

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  32. NRS-033

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  33. NT-301 1 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Tolerability of NT-301 Nasal Spray

    phase 1 other completed

    1 trial

  34. NX210c

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Elderly

    phase 1 small molecule completed

    1 trial

  35. Nafamostat Mesilate

    BRIGHT MINDS BIOSCIENCES INC.

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  36. Nalmefene

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 1 small molecule completed

    1 trial

  37. Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Overdose

    phase 1 small molecule completed

    1 trial

  38. Naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  39. Naloxone Hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule terminated

    1 trial

  40. Naltrexone and Bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 1 small molecule completed

    1 trial

  41. Naltrexone implant, 14.4 grams

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 small molecule active

    1 trial

  42. Narcan 40 MG/ML Nasal Spray

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Induced Respiratory Depression

    phase 1 small molecule active

    1 trial

  43. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 1 small molecule completed

    1 trial

  44. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Addiction

    phase 1 small molecule completed

    1 trial

  45. Nicotine (Pharmaceutical Productions Inc.)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pharmacokinetic Study

    phase 1 small molecule completed

    1 trial

  46. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 1 small molecule completed

    1 trial

  47. Nicotine Pouches

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Pouch Self-Administration

    phase 1 small molecule active

    1 trial

  48. Nicotine Replacement Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.